Nausea occurs in approximately 20 to 30 percent of individuals during dose escalation
Despite the lower number of reports, the statistical signal for Wegovy was much stronger, with odds nearly 75 times higher than expected
Unlike GLS2, GLS1 is often overexpressed in many types of cancer, including breast cancer, acute myeloid leukemia, and non-small cell lung cancer, making it a promising therapeutic target for cancer treatment (Van Den Heuvel et al., 2012
The combination of semaglutide with other treatments should be carefully managed by a healthcare provider to optimize therapeutic outcomes and minimize the risk of hypoglycemia, especially when used with insulin or sulfonylureas
Glucagon-like peptide 1 (GLP-1) is a hormone your body naturally releases after you eat